Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free COCP Stock Alerts

Cocrystal Pharma (COCP) News Today

Cocrystal Pharma logo
$1.13 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern
Compare

Cocrystal Pharma Latest News

COCP: $5 Million Private Placement with OPKO Health
August 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/cocp-5-million-private-placement-112000829.html
Cocrystal Pharma strengthens board with antiviral expert appointment
August 19, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/COCP/pressreleases/3916268/cocrystal-pharma-strengthens-board-with-antiviral-expert-appointment/
Cocrystal Pharma Adds Veteran Leader to Board of Directors
August 18, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/cocrystal-pharma-adds-veteran-leader-to-board-of-directors?utm_source=marketbeat.com&utm_medium=referral
Cocrystal Pharma, Inc.: Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
August 17, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69333189-cocrystal-pharma-inc-cocrystal-pharma-appoints-carol-brosgart-md-to-its-board-of-directors-399.htm
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors
August 17, 2026  |  quiverquant.comQ
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
August 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/17/3346271/0/en/cocrystal-pharma-appoints-carol-brosgart-md-to-its-board-of-directors.html
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
August 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/03/3337355/0/en/cocrystal-pharma-announces-5-million-private-placement-with-opko-health.html
Cocrystal Pharma Shareholders Approve Governance and Oversight Measures
July 17, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/cocrystal-pharma-shareholders-approve-governance-and-oversight-measures?utm_source=marketbeat.com&utm_medium=referral
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
June 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/03/3305904/0/en/cocrystal-pharma-appoints-james-sapirstein-biopharma-industry-leader-with-extensive-antiviral-development-experience-as-chief-executive-officer.html
COCP: Presentation highlights CDI-988
June 1, 2026  |  msn.comhttps://www.msn.com/en-us/health/medical/cocp-presentation-highlights-cdi-988/ar-AA24yBrl
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
May 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/26/3301025/0/en/cocrystal-pharma-announces-discovery-of-pan-viral-inhibitors-targeting-hantavirus-bunyavirus-and-influenza.html
Cocrystal Pharma Inc
May 17, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/COCP
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
May 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/15/3295782/0/en/cocrystal-pharma-provides-business-update-and-reports-first-quarter-2026-financial-results.html
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
April 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/30/3285434/0/en/cocrystal-pharma-presentation-at-icar-2026-highlights-mechanism-of-action-and-clinical-advancement-of-cdi-988-for-the-prevention-and-treatment-of-norovirus-infection.html
Cocrystal Pharma (COCP) price target increased by 33.33% to 8.16
April 16, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/cocrystal-pharma-cocp-price-target-increased-by-33-33-to-8-16/ar-AA20VRKV
We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate
April 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/were-keeping-eye-cocrystal-pharmas-125701156.html
(PMZN) Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
April 3, 2026  |  marketwatch.comhttps://www.marketwatch.com/press-release/pmzn-cocrystal-pharma-receives-fda-fast-track-designation-for-cdi-988-for-norovirus-infection-treatment-and-preventive-a6c77290
Cocrystal Pharma stock surges on FDA Fast Track designation
April 2, 2026  |  za.investing.comhttps://za.investing.com/news/stock-market-news/cocrystal-pharma-stock-surges-on-fda-fast-track-designation-93CH-4195979
COCP stock soars 75% — what is the link to Cocrystal’s norovirus treatment?
April 2, 2026  |  msn.comhttps://www.msn.com/en-us/money/general/cocp-stock-soars-75-what-is-the-link-to-cocrystal-s-norovirus-treatment/ar-AA200Ath
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988
April 2, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/26/04/51626215/cocrystal-pharma-shares-soar-after-fda-grants-fast-track-status-to-cdi-988?utm_source=snapi
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
April 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/02/3267307/0/en/cocrystal-pharma-receives-fda-fast-track-designation-for-cdi-988-for-norovirus-infection-treatment-and-preventive.html
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
March 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/31/3265429/0/en/cocrystal-pharma-reports-2025-financial-results-and-provides-updates-on-its-antiviral-drug-development-programs.html
First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
March 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/first-subjects-dosed-cocrystal-pharma-120000071.html
First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
March 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/09/3251781/0/en/first-subjects-dosed-in-cocrystal-pharma-s-phase-1b-study-evaluating-cdi-988-for-norovirus-prevention-and-treatment.html
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
February 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/19/3241010/0/en/cocrystal-pharma-s-first-oral-norovirus-protease-inhibitor-cdi-988-to-be-featured-at-the-international-society-for-antiviral-research-conference-icar-2026.html
Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Acquires 50,000 Shares
February 10, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-cocp-insider-buying-and-selling-2026-02-10/
Phillip Md Et Al Frost Acquires 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock
January 3, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-cocp-insider-buying-and-selling-2026-01-03/
Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Buys 20,000 Shares
January 1, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-cocp-insider-buying-and-selling-2026-01-01/
Phillip Md Et Al Frost Buys 25,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock
December 30, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-cocp-insider-buying-and-selling-2025-12-30/
Cocrystal Pharma gains IRB approval for norovirus trial
December 19, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/cocrystal-pharma-gains-irb-approval-for-norovirus-trial/ar-AA1SCaMD
Cocrystal Pharma receives IRB approval from Emory University for Phase 1b trial
December 18, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/cocrystal-pharma-receives-irb-approval-from-emory-university-for-phase-1b-trial/ar-AA1SBLFw
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
December 18, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/18/3207637/0/en/cocrystal-pharma-receives-irb-approval-from-emory-university-school-of-medicine-for-phase-1b-human-challenge-study-with-cdi-988-for-prevention-and-treatment-of-norovirus.html
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
December 1, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/cocrystal-pharma-present-noble-capital-130000460.html
Cocrystal Pharma, Inc. to Present Clinical Progress Update at NobleCon 21 Conference
December 1, 2025  |  quiverquant.comQ
Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference
December 1, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/01/3196941/0/en/cocrystal-pharma-to-present-at-the-noble-capital-markets-21st-emerging-growth-equity-conference.html
Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Purchases 20,000 Shares
November 26, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-cocp-insider-buying-and-selling-2025-11-26/
Cocrystal Pharma reports Q3 EPS (19c) vs (49c) last year
November 14, 2025  |  msn.comhttps://www.msn.com/en-us/health/diseases-and-conditions/cocrystal-pharma-reports-q3-eps-19c-vs-49c-last-year/ar-AA1QscIn
Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
November 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/11/14/3188274/0/en/cocrystal-pharma-reports-third-quarter-2025-financial-results-and-provides-updates-on-its-antiviral-drug-development-programs.html
Cocrystal Pharma Completes $1.03M Private Placement
October 30, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/cocrystal-pharma-completes-1-03m-private-placement/ar-AA1PvMw3
Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules
October 30, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/30/3177339/0/en/cocrystal-pharma-insiders-purchase-1-03-million-in-private-placement-priced-at-the-market-under-nasdaq-rules.html
Cocrystal Pharma (COCP) Price Target Increased by 14.29% to 8.16
October 30, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/cocrystal-pharma-cocp-price-target-increased-by-1429-to-816/ar-AA1PtE3s
Cocrystal Pharma receives NIH SBIR award to advance influenza inhibitor program
October 28, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/cocrystal-pharma-receives-nih-sbir-award-to-advance-influenza-inhibitor-program/ar-AA1Phz24
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program
October 27, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/27/3174513/0/en/cocrystal-pharma-receives-nih-sbir-award-to-advance-its-influenza-inhibitor-program.html
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
October 2, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/02/3160321/0/en/cocrystal-pharma-to-present-at-noble-capital-markets-emerging-growth-virtual-equity-conference.html
Cocrystal Pharma files to sell 5.74M shares of common stock for holders
September 19, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/cocrystal-pharma-files-to-sell-5-74m-shares-of-common-stock-for-holders/ar-AA1MVdVl
Cocrystal Pharma, Inc. Closes $4.7 Million Registered Direct Offering with Additional $8.3 Million Potential from Warrants
September 15, 2025  |  quiverquant.comQ
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 15, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/15/3150405/0/en/cocrystal-pharma-inc-announces-closing-of-up-to-13-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules.html
Cocrystal Pharma announces up to $13M registered direct offering
September 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/cocrystal-pharma-announces-up-to-13m-registered-direct-offering/ar-AA1MqRos
Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 12, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/12/3149259/0/en/cocrystal-pharma-inc-announces-up-to-13-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules.html
Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference
September 12, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/12/3149161/0/en/cocrystal-pharma-showcases-cdi-988-the-first-oral-antiviral-in-development-for-norovirus-infection-in-a-podium-presentation-at-the-international-calicivirus-conference.html

Cocrystal Pharma Media Mentions By Week

Cocrystal Pharma Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

COCP
News Sentiment
▼
0.00

0.78
▲
Average
Healthcare
News Sentiment

Cocrystal Pharma News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

COCP Articles
This Week
▼
0

2
▲
COCP Articles
Average Week

Cocrystal Pharma Trends on MarketBeat

This week vs. last week
Searches
1
Page Views
1,851
+32%
Get Cocrystal Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Cocrystal Pharma dated 8/20/2026.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel